OKYO Pharma (OKYO) IPO Opens 13% Higher

Today's IPO for OKYO Pharma Limited (Nasdaq: OKYO) opened for trading at $4.50 per ADS after pricing 625,000 ADSs (representing 40,625,000 new ordinary shares of no par value) at a price of $4.00 per ADS.

ThinkEquity LLC was the sole bookrunning manager for the IPO.

OKYO Pharma is a life sciences company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and ocular pain.

You May Also Be Interested In

• Vogenx prices IPO at $13 per share, raising $81.3M
• TCGX Acquisition Corp. raises $86.25M in Nasdaq IPO
• Braveheart Bio raises $439.9M in upsized Nasdaq IPO